🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Happy Giving Tuesday! To celebrate, we've published a list of charities our program staff recommend to individual donors. (Link in next post.) Congrats to Center for Global Development, Cures Within Reach, WaitList Zero, GiveWell, Founders Pledge, Doneer Effectief, Sage, Speculative Technologies,

One secret to our success? Our Grant Review Committee members, nearly 100 strong in 2024. The Dec enewsletter also shares 6 #LMIC-based #ClinicalTrials recently selected, our expanded partnership with Open Philanthropy and spotlights Dr Nichols of St. Jude. Read bit.ly/3ZIDz7E

Today we announced a grant from Chan Zuckerberg Initiative to fund #ClinicalTrials that validate AI-generated drug-disease repurposing matches. Read more here: cureswithinreach.org/2024/12/17/pre… #AI #Repurposing #RareDisease

This The New York Times story about #snakebite treatment is a great example of why and how together our efforts impact #LMIC patients by repurposing already approved treatments. cureswithinreach.org/2020/10/07/tes… Open Philanthropy

This The New York Times story about #snakebite treatment is a great example of why and how our efforts impact #LMIC patients by repurposing already approved treatments. cureswithinreach.org/2020/10/07/tes… Open Philanthropy KEMRI-Wellcome Trust

This The New York Times story highlights why and how our efforts are impacting #LMIC patients by repurposing already approved treatments. cureswithinreach.org/2020/10/07/tes… Open Philanthropy KEMRI-Wellcome Trust

This The New York Times story about #snakebite treatment touches upon the need for more accessible treatment options for #LMIC patients including the unithiol option we supported cureswithinreach.org/2020/10/07/tes… Open Philanthropy KEMRI-Wellcome Trust

New year - new RFPs! Read about our upcoming funding of #ClinicalTrials to validate #AI drug disease #repurposing predictions, upcoming RFPs, new trials recently selected, Dr. Rizk of Medical University of South Carolina (MUSC) and more in our Jan enewsletter: bit.ly/3CeqN7Z

Announcing our 2024 Annual Report: $29 mil raised in follow-on funding. Help spread the word to impact more patients: bit.ly/CWRAR24. Thanks to our stakeholders: together we are improving quality of life for patients faster through repurposing. They are counting on us.

Our 2025 #LMIC-focused RFP is now accepting LOIs until 3.28. Read about this and other #ClinicalTrial funding available plus our Researcher Spotlight for Feb Dr. Stanley Zimba of University of Zambia in our Feb enewsletter out now: bit.ly/3X9FBfc

Today on Rare Disease Day we are honored to collaborate with clinical researchers around the world to impact #RareDisease patients in our 22 ongoing clinical #Repurposing trials. cureswithinreach.org/audiences/rare… Driving more treatments to more patients more quickly

Calling all ITM researchers! Cures Within Reach is seeking repurposed treatments in the following areas: Health Equity, Early Stage Investigators, Pediatrics, and/or Veterans/Military. Budgets of up to $100K are accepted. Apply by April 18! chicagoitm.org/events/get-up-…

Great example of the impact already approved therapies can have on patients. We’re proud to be a collaborator with LSTM and KEMRI-Wellcome Trust on this snakebite treatment option. Thanks to Open Philanthropy for furthering this #PatientImpact!

Need #ClinicalTrial funding? We have 3 open RFPs plus more coming soon. Read more + our spotlight on Dr Robin Voigt-Zuwala of Rush University in our March enewsletter. bit.ly/4bGtfBx

Clinical trial funding avail for #Meniere's disease and related diagnoses anywhere in the world testing approved treatments – LOI deadline Jun 13. Spread the word! Visit cureswithinreach.org/programs/fundi…. #ClinicalTrials #Repurposing Vestibular Disorders Hearing Health Foundation American Hearing RF

#ClinicalTrial funding available – submissions due this Spring/Summer. Read more plus our researcher spotlight on Dr. Desmond Oathes 🧲🧠⚡️👨🏻‍💻 of Penn Medicine in our April enewsletter: bit.ly/3ExU2DY

There are 10 days until the deadline for the Cures Within Reach RFP for Chicago-area clinical repurposing trials in the following areas: Health Equity (including women's health), Early Stage Investigators, Pediatrics and Veterans/Military — bit.ly/cwrrfps

Apply for clinical trial funding! Read more plus our researcher spotlight: Dr. Sheldon L. Holder of Legorreta Cancer Center at Brown University and Dr. Sawa Ito's publication of her successful AML trial at University of Pittsburgh in our May enewsletter: bit.ly/43nUqNJ #ImpactPhilanthropy #Repurposing

On #InternationalClinicalTrialsDay, we are honored to be collaborating with 41 research institutions in 52 trials around the world to impact patients in 38 different unsolved diseases - building clinical evidence for regulatory approval or off-label use cureswithinreach.org/programs/curre…

May is #NationalCancerResearchMonth. ~15% of generics have shown promise for treating new cancer indications, but we need clinical trials to prove what works. Check out the funding opportunity for AI-driven trials from Cures Within Reach & Chan Zuckerberg Initiative! #TheSolutionMayAlreadyExist